Search for: "In Re Biopharma V"
Results 1 - 16
of 16
Sorted by Relevance
|
Sort by Date
19 Apr 2021, 6:04 am
Cir. 2003), and In re Angstadt, 537 F.2d 498 (C.C.P.A. 1976). [read post]
11 Apr 2023, 2:44 pm
Cir. 2020) (quoting In re Kubin, 561 F.3d 1351, 1357 (Fed. [read post]
31 Jul 2023, 1:47 pm
Cir. 2020) (quoting In re Kubin, 561 F.3d 1351, 1357 (Fed. [read post]
8 Jun 2023, 7:43 am
Horizon’s strategy shifted over time, however, with the firm seeking to purchase undervalued therapeutics from bankrupt pharmaceutical companies and then re-launch them. [read post]
24 Mar 2014, 4:15 am
See Allergan, Inc. v. [read post]
8 Jun 2023, 7:43 am
Horizon’s strategy shifted over time, however, with the firm seeking to purchase undervalued therapeutics from bankrupt pharmaceutical companies and then re-launch them. [read post]
13 Oct 2015, 9:10 am
Even biopharma patents will be cheaply infringed. [read post]
11 Jan 2011, 11:07 pm
Highlights this week included: US: CAFC : Single embodiment commercial success: In re Glatt Air Techniques (Patently-O) (Patents Post Grant Blog) (PharmaPatents) (IPBiz) US: Reverse payment settlements return to the Supreme Court: Louisiana Wholesale Drug Co et al v Bayer et al (Patently-O) (FDA Law Blog) Kaletra (Ritonavir, Lopinavir) – India: Abbott’s patent on AIDS medicine denied (IP Watch) (Spicy IP) (SiNApSE) Please join the discussion by adding your comments on… [read post]
1 Dec 2007, 9:00 am
(UK Channel Management Ltd v E! [read post]
19 Feb 2021, 2:28 am
In its latest decision on this topic, Amgen Inc. et al. v. [read post]
6 Feb 2009, 5:00 am
Stem cell research under Obama (Ars Technica) US: Oxford Gene Technology settles legal action with Bioarray Solutions over patents covering use of microassays for detection of DNA sequence variations (Patent Docs) US: BPAI affirms rejection of claims to an isolated protein over prior art disclosing nucleic acid encoding the protein: Ex parte Chuang (not precedential) (Patent Docs) (Post-Grant) US: Supreme petitioned to grant certiorari in two cases important to biotech patenting: In re… [read post]
19 Jul 2022, 2:59 pm
., Sarafin v. [read post]
9 Jan 2009, 3:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Humira (Adalimumab) – US: Bayer HealthCare files patent infringement suit against Abbott Laboratories over Humira; Abbott fires back with lawsuit claiming Bayer’s patent invalid, not infringed or unenforceable (Law360) (Law360) (Philip Brooks' Patent Infringement Updates) (Patent Baristas) Sprycel (Dasatinib)… [read post]
25 Jul 2022, 2:50 pm
“I know private equity does this in other industries, but in medicine you’re dealing with people’s health and their lives,” says Michael Rains, a doctor who worked at U.S. [read post]
28 Nov 2011, 4:02 am
Courts have precluded the use of class actions against drug makers in most cases (see, e.g., Valentino v. [read post]
23 Dec 2007, 8:00 pm
: (IPEG),More on the implementation of the London Agreement and patent cost reduction in Europe: (Patent Baristas),ECJ rules that EU legislative obligations cannot be enforced in any Member State if that legislation has not been published in the Official Journal in the language of that Member State (Case C-161/06 OlomoucSkoma-Lux sro v Celni reditelstvi Olumouc): (IPKat),EPO fighting complex appl [read post]
